Literature DB >> 14703720

The preventive effect of captopril or enalapril on reperfusion injury of the kidney of rats is independent of angiotensin II AT1 receptors.

Hamid Reza Pazoki-Toroudi1, Ali Hesami, Simin Vahidi, Farhad Sahebjam, Behjat Seifi, Bijan Djahanguiri.   

Abstract

Occlusion of the artery of organs results in ischaemia. The opening of occluded artery results in tissue lesion identified as reperfusion injury (RI). Renin-angiotensin system seems to be involved in the RI. In this study we assessed the effects of different doses of two inhibitors of angiotensin converting enzyme (captopril or enalapril) and an angiotensin receptor type 1 (AT1) receptor blocker (losartan) in the RI of the kidney of rats. Female rats of 200-250 g were anaesthetized and used for RI studies. Different doses of captopril (5, 20 and 80 mg/kg), enalapril (1, 4 and 16 mg/kg) and/or losartan (5, 10 and 20 mg/kg) were used (s.c.) 120 min prior to the initiation of RI. Kidneys were removed and checked histologically for the presence and the grading of ischaemic injury. Appropriate controls were used as well, RI produced lesions comparable with that of ischaemia. Different doses of captopril or enalapril prevented these lesions. This is suggestive of the involvement of renin-angiotensin system in the RI. Different doses of losartan failed to prevent RI lesions which suggest that the effect of captopril or enalapril are not mediated through the AT1 receptors. Further studies on the involvement of AT2 receptor or other independent mechanisms are suggested.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703720     DOI: 10.1046/j.1472-8206.2003.00188.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  8 in total

1.  Hesperidin improves the follicular development in 3D culture of isolated preantral ovarian follicles of mice.

Authors:  Hamed Shoorei; Majid Banimohammad; Maziar M Kebria; Mohammad Afshar; Mohammad Mh Taheri; Majid Shokoohi; Mohammad Sg Farashah; Mina Eftekharzadeh; Omid Akhiani; Robert Gaspar; Hamidreza Pazoki-Toroudi
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-19

Review 2.  The kallikrein-kinin system in health and in diseases of the kidney.

Authors:  Masao Kakoki; Oliver Smithies
Journal:  Kidney Int       Date:  2009-02-04       Impact factor: 10.612

Review 3.  Novel roles of the renal angiotensin-converting enzyme.

Authors:  Jorge F Giani; Luciana C Veiras; Justin Z Y Shen; Ellen A Bernstein; DuoYao Cao; Derick Okwan-Duodu; Zakir Khan; Romer A Gonzalez-Villalobos; Kenneth E Bernstein
Journal:  Mol Cell Endocrinol       Date:  2021-03-26       Impact factor: 4.369

4.  Preclinical study of Shen Qi Li Xin formula in improving the development of chronic heart failure.

Authors:  Yan-Bo Sui; Kui-Kui Zhang; Li-Yun Ling; Rui Fan; Li Liu
Journal:  Histol Histopathol       Date:  2022-03-25       Impact factor: 2.130

5.  Sub-Flap Use of Nano-Selenium Oxide Solution Enhances Skin Flap Viability in Rats: Study the Novel Role of mTOR and p-mTOR Expression.

Authors:  Omid Akhiani; Nasim Zangouie; Reza Laripour; Amir Rashidian; Mohsen Ebrahimi; Zahra Hami; Mohsen Chamanara
Journal:  Aesthetic Plast Surg       Date:  2022-01-20       Impact factor: 2.708

Review 6.  Renal ischemia/reperfusion injury; from pathophysiology to treatment.

Authors:  Maryam Malek; Mehdi Nematbakhsh
Journal:  J Renal Inj Prev       Date:  2015-06-01

7.  Would Colloidal Gold Nanocarriers Present An Effective Diagnosis Or Treatment For Ischemic Stroke?

Authors:  Hamed Amani; Ebrahim Mostafavi; Mahmoud Reza Alebouyeh; Hamidreza Arzaghi; Abolfazl Akbarzadeh; Hamidreza Pazoki-Toroudi; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2019-10-07

8.  The Novel Role of Crocus sativus L. in Enhancing Skin Flap Survival by Affecting Apoptosis Independent of mTOR: A Data-Virtualized Study.

Authors:  Zahra Habibi; Mahmood Hoormand; Majid Banimohammad; Marjan Ajami; Gholamreza Amin; Mohsen Amin; Hamidreza Pazoki-Toroudi
Journal:  Aesthetic Plast Surg       Date:  2022-08-31       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.